Figure 1. TSS score before and after treatment. ITT population; mean values and SD. Changes are statistically significant (P < 0.001).
| Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc |
| Journal website http://www.jcgo.org |
Original Article
Volume 6, Number 1, March 2017, pages 6-11
Clinical Evaluation of the Efficacy and Safety of a Medical Vaginal Device Containing Rigenase® for the Treatment of Vaginosis: A Randomized Study
Figure
Tables
| Cream | Vaginal suppository | Vaginal solution | Gel | Foam | Total | |
|---|---|---|---|---|---|---|
| n | 15 | 15 | 15 | 15 | 15 | 75 |
| Age (years) | 38 ± 13 | 38 ± 14 | 35 ± 10 | 45 ± 11 | 37 ± 12 | 39 ± 12 |
| Weight (kg) | 67 ± 14 | 69 ± 11 | 63 ± 11 | 63 ± 9 | 66 ± 16 | 65 ± 12 |
| Height (cm) | 164 ± 8 | 161 ± 6 | 161 ± 6 | 160 ± 7 | 162 ± 7 | 162 ± 7 |
| BMI (kg/cm2) | 25 ± 5 | 27 ± 4 | 24 ± 4 | 25 ± 3 | 25 ± 6 | 25 ± 5 |
| Cream | Vaginal suppositories | Vaginal solution | Gel | Foam | |
|---|---|---|---|---|---|
| Pain | |||||
| Before | 1.3 | 0.4 | 0.2 | 0.5 | 0.8 |
| After | 0.6 | 0.1 | 0 | 0.1 | 0.1 |
| Burning | |||||
| Before | 1.5 | 1.5 | 1.7 | 1.6 | 1.5 |
| After | 0.3 | 0.5 | 0.5 | 0.5 | 0.3 |
| Itch | |||||
| Before | 1.3 | 1.2 | 1.7 | 1.3 | 1.2 |
| After | 0.1 | 0.3 | 0.4 | 0.3 | 0.3 |
| Dry vagina sense | |||||
| Before | 1.5 | 1.7 | 1.4 | 1.3 | 1.7 |
| After | 0.5 | 0.2 | 0.4 | 0.1 | 0.6 |
| Dyspareunia | |||||
| Before | 0.7 | 1.2 | 1.3 | 0.9 | 0.9 |
| After | 0.2 | 0.3 | 0.4 | 0.3 | 0.3 |
| Dysuria | |||||
| Before | 0.2 | 0.2 | 0.1 | 0.1 | 0.4 |
| After | 0.1 | 0 | 0 | 0.1 | 0.1 |
| Vaginal discharge | |||||
| Before | 2.4 | 1.9 | 2 | 1.5 | 1.7 |
| After | 0.5 | 0.8 | 0.5 | 0.5 | 0.5 |
| Vulvovaginal erythema | |||||
| Before | 1.7 | 1.3 | 1.7 | 1.6 | 2.0 |
| After | 0.3 | 0.3 | 0.3 | 0.4 | 0.6 |